Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement a Placement of Aortic Transcatheter Valves (PARTNER)-I trial substudy

Circulation

Volumn 131, Issue 22, 2015, Pages 1989-1999

  Blackstone, Eugene H ^a   Suri, Rakesh M ^b   Rajeswaran, Jeevanantham ^a   Babaliaros, Vasilis ^c   Douglas, Pamela S ^d   Fearon, William F ^e   Miller, D Craig ^e   Hahn, Rebecca T ^f   Kapadia, Samir ^a   Kirtane, Ajay J ^f   Kodali, Susheel K ^f   Mack, Michael ^g   Szeto, Wilson Y ^h   Thourani, Vinod H ^c   Tuzcu, E Murat ^a   Williams, Mathew R ⁱ   Akin, Jodi J ^j   Leon, Martin B ^f   Svensson, Lars G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c EMORY UNIVERSITY   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f NewYork Presbyterian Hospital   (United States)

^g SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^j NONE

more..

Author keywords

Aortic valve insufficiency; Mortality; Propensity score; Stroke; Transcatheter aortic valve replacement

Indexed keywords

ADVERSE OUTCOME; AGED; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROPENSITY SCORE; TRANSAPICAL TRANSCATHETER AORTIC VALVE REPLACEMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT; VASCULAR ACCESS; VASCULAR DISEASE; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; CLINICAL TRIAL; FEMORAL ARTERY; HEART CATHETERIZATION; LONGITUDINAL STUDY; MORTALITY; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MORTALITY; PROPENSITY SCORE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84935484678     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.012525     Document Type: Article

References (24)

1. Wilbring M, Alexiou K, Schumann E, Matschke K, Tugtekin SM. Isolated aortic valve replacement in patients with small aortic annulus-a high-risk group on long-term follow-up. Thorac Cardiovasc Surg. 2013;61:379-385. doi: 10.1055/s-0032-1331577.
2. Antunes MJ. Aortic stenosis in octogenarians and other high-risk groups: what can surgical valve replacement offer? Eur J Cardiothorac Surg. 2012;42:940-941. doi: 10.1093/ejcts/ezs232.
3. Santarpino G, Pfeiffer S, Fischlein T. Favourable outcomes after high-risk conventional aortic valve replacement: can we do even better? Eur J Cardiothorac Surg. 2012;41:1218-1219; author reply 1219. doi: 10.1093/ejcts/ezr186.
4. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198. doi: 10.1056/NEJMoa1103510.
5. Miller DC, Blackstone EH, Mack MJ, Svensson LG, Kodali SK, Kapadia S, Rajeswaran J, Anderson WN, Moses JW, Tuzcu EM, Webb JG, Leon MB, Smith CR; PARTNER Trial Investigators and Patients; PARTNER Stroke Substudy Writing Group and Executive Committee. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143:832-843.e13. doi: 10.1016/j.jtcvs.2012.01.055.
6. Svensson LG, Dewey T, Kapadia S, Roselli EE, Stewart A, Williams M, Anderson WN, Brown D, Leon M, Lytle B, Moses J, Mack M, Tuzcu M, Smith C. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008;86:46-54. doi: 10.1016/j.athoracsur.2008.04.049.
7. Hahn RT, Pibarot P, Stewart WJ, Weissman NJ, Gopalakrishnan D, Keane MG, Anwaruddin S, Wang Z, Bilsker M, Lindman BR, Herrmann HC, Kodali SK, Makkar R, Thourani VH, Svensson LG, Akin JJ, Anderson WN, Leon MB, Douglas PS. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (Placement of Aortic Transcatheter Valves). J Am Coll Cardiol. 2013;61:2514-2521. doi: 10.1016/j.jacc.2013.02.087.
8. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57:253-269.
9. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R: Foundation for Statistical Computing; 2014.
10. Breiman L. Bagging predictors. Machine Learning. 1996;24:123-140.
11. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med. 1992;11:2093-2109.
12. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
13. Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med. 2007;26:20-36. doi: 10.1002/sim.2739.
14. Bergstralh EJ, Konsanke JL. Computerized Matching of Cases to Controls. Rochester, MN: Mayo Clinic Department of Health Sciences Research; 1995. Technical Report Series, No. 56.
15. Blackstone EH. Comparing apples and oranges. J Thorac Cardiovasc Surg. 2002;123:8-15.
16. Blackstone EH, Naftel DC, Turner ME Jr. The decomposition of timevarying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc. 1986;81:615-624.
17. Rubin DB. Multiple Imputation for Non-Response in Surveys. New York, NY: Wiley; 1987.
18. Détaint D, Lepage L, Himbert D, Brochet E, Messika-Zeitoun D, Iung B, Vahanian A. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv. 2009;2:821-827. doi: 10.1016/j.jcin.2009.07.003.
19. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695. doi: 10.1056/NEJMoa1200384.
20. Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, Tarantini G, Sinning JM, Nickenig G, Capodanno D, Tamburino C, Latib A, Colombo A, Kapadia SR. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61:1585-1595. doi: 10.1016/j.jacc.2013.01.047.
21. Dewey TM, Bowers B, Thourani VH, Babaliaros V, Smith CR, Leon MB, Svensson LG, Tuzcu EM, Miller DC, Teirstein PS, Tyner J, Brown DL, Fontana GP, Makkar RR, Williams MR, George I, Kirtane AJ, Bavaria JE, Mack MJ. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg. 2013;96:2083-2089. doi: 10.1016/j.athoracsur.2013.05.093.
22. Blackman DJ, Baxter PD, Gale CP, Moat NE, Maccarthy PA, Hildick-Smith D, Trivedi U, Cunningham D, DE Belder MA, Ludman PF; National Institute for Cardiovascular Outcomes Research (NICOR). Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry. J Interv Cardiol. 2014;27:86-95. doi: 10.1111/joic.12084.
23. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705-1715. doi: 10.1056/NEJMoa1114705.
24. Hemmann K, Sirotina M, De Rosa S, Ehrlich JR, Fox H, Weber J, Moritz A, Zeiher AM, Hofmann I, Schächinger V, Doss M, Sievert H, Fichtlscherer S, Lehmann R. The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase. Interact Cardiovasc Thorac Surg. 2013;17:359-364. doi: 10.1093/icvts/ivt132.